Retatrutide, an Agonist of GIP, GLP-1, and Glucagon Receptors, Improves Markers of Pancreatic Beta-Cell Function and Insulin Sensitivity

被引：0
|
作者：
Rosenstock, Julio
Coskun, Tamer
Hartman, Mark L.
Lou, Jitong
Wu, Qiwei
Du, Yu
Gurbuz, Sirel
Mather, Kieren J.
Milicevic, Zvonko
Thomas, Melissa K.
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-266-OR
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
266-OR
引用
收藏
页数：2
相关论文
共 50 条
  • [1] TIRZEPATIDE, A DUAL GIP AND GLP-1 RECEPTOR AGONIST, INCREASES INSULIN SENSITIVITY AND IMPROVES PANCREATIC BETA-CELL FUNCTION IN TYPE 2 DIABETES
    Pirro, V.
    Nikooienejad, A.
    Lin, Y.
    Willency, J.
    Wilson, J.
    Duffin, K.
    Robins, D.
    Milicevic, Z.
    Haupt, A.
    Thomas, M.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A165 - A165
  • [2] Tirzepatide, a Dual GIP and GLP-1 Receptor Agonist, Improves Markers of Beta-Cell Function and Insulin Sensitivity in Type 2 Diabetes Patients
    Thomas, Melissa K.
    Nikooienejad, Amir
    Bray, Ross
    Cui, Xuewei
    Wilson, Jonathan M.
    Duffin, Kevin L.
    Milicevic, Zvonko
    Haupt, Axel
    Robins, Deborah A.
    [J]. DIABETES, 2019, 68
  • [3] Dual GIP and GLP-1 Receptor Agonist Tirzepatide Improves Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes
    Thomas, Melissa K.
    Nikooienejad, Amir
    Bray, Ross
    Cui, Xuewei
    Wilson, Jonathan
    Duffin, Kevin
    Milicevic, Zvonko
    Haupt, Axel
    Robins, Deborah A.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (02): : 388 - 396
  • [4] Tirzepatide, a dual GIP and GLP-1 receptor agonist, improves markers of beta cell function and insulin sensitivity in type 2 diabetes patients
    Thomas, M. K.
    Nikooienejad, A.
    Bray, R.
    Cui, X.
    Wilson, J.
    Duffin, K.
    Milicevic, Z.
    Haupt, A.
    Robins, D. A.
    [J]. DIABETOLOGIA, 2019, 62 : S354 - S354
  • [5] The novel GIP, GLP-1 and glucagon receptor agonist retatrutide delays gastric emptying
    Urva, Shweta
    O'Farrell, Libbey
    Du, Yu
    Loh, Mei Teng
    Hemmingway, Andrea
    Qu, Hongchang
    Alsina-Fernandez, Jorge
    Haupt, Axel
    Milicevic, Zvonko
    Coskun, Tamer
    [J]. DIABETES OBESITY & METABOLISM, 2023, 25 (09): : 2784 - 2788
  • [6] Lack of Synergy for Glucagon and GLP-1 on Acute Beta-Cell Function and Insulin Sensitivity in Mice
    Pacini, Giovanni
    Ahren, Bo
    [J]. DIABETES, 2014, 63 : A452 - A452
  • [7] GLP-1 agonist liraglutide improves insulin sensitivity
    Di Lellis, Maddalena Angela
    [J]. DIABETOLOGIE UND STOFFWECHSEL, 2024, 19 (03) : 172 - 172
  • [8] Sex, Age and BMI Predict Weight Loss Response to the GIP/GLP-1/Glucagon Receptor Agonist Retatrutide
    Jastreboff, Ania
    Kaplan, Lee
    Frias, Juan
    Wu, Qiwei
    Du, Yu
    Coskun, Tamer
    Haupt, Axel
    Milicevic, Zvonko
    Hartman, Mark
    [J]. OBESITY, 2023, 31 : 27 - 27
  • [9] Is retatrutide (LY3437943), a GLP-1, GIP, and glucagon receptor agonist a step forward in the treatment of diabetes and obesity?
    Doggrell, Sheila A.
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2023, 32 (05) : 355 - 359
  • [10] Triagonism Targeting GCGR/GLP-1/GIP-1 Receptors Improves Insulin Sensitivity in Obese Mice
    Kim, Teayoun
    Nason, Shelly
    Antipenko, Jessica
    Habegger, Kirk M.
    [J]. DIABETES, 2023, 72
12345